An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Hearing loss in adults: assessment and management.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Jun. (NICE Guideline, No. 98.)
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Triple-negative breast cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
Thyroid cancer: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Dec 19. (NICE Guideline, No. 230.)
Brain tumours (primary) and brain metastases in adults.
London: National Institute for Health and Care Excellence (NICE); 2021 Jan 29. (NICE Guideline, No. 99.)
Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 148.)
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Clinical Excellence (NICE); 2012 Sep. (NICE Clinical Guidelines, No. 151.)
CADTH Canadian Drug Expert Committee Recommendation: Cladribine (Mavenclad — EMD Serono): Indication: Relapsing-Remitting Multiple Sclerosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Nivolumab and Relatlimab (Opdualag): CADTH Reimbursement Recommendation: Indication: For the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma who have not received prior systemic therapy for unresectable or metastatic melanoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb.
CADTH Canadian Drug Expert Committee Recommendation: Ocrelizumab (Ocrevus ‒ Hoffmann-La Roche Limited): Indication: Management of adult patients with early primary progressive multiple sclerosis (PPMS) as defined by disease duration and level of disability, in conjunction with imaging features characteristic of inflammatory activity [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr 30.
Comparing Medicines for Long-Term Treatment of Bipolar Disorder [Internet].
Nestsiarovich A, Hurwitz NG, Kerner B, et al.
Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Mar.
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda.
Washington (DC): National Academies Press (US); 2017 Jan 12.
Cabozantinib (Cabometyx): CADTH Reimbursement Recommendation: Indication: Cabozantinib, in combination with nivolumab, is indicated for the first-line treatment of adult patients with advanced (not amenable to curative surgery or radiation therapy) or metastatic renal cell carcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Cemiplimab (Libtayo): CADTH Reimbursement Recommendation: Indication: For the treatment of patients with locally advanced basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Spinal metastases and metastatic spinal cord compression.
London: National Institute for Health and Care Excellence (NICE); 2023 Sep 6. (NICE Clinical Guidelines, No. 234.)
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda [Internet].
Geneva: World Health Organization; 2022.
Non-Hodgkin's Lymphoma: Diagnosis and Management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Preoperative Tests (Update): Routine Preoperative Tests for Elective Surgery.
London: National Institute for Health and Care Excellence (NICE); 2016 Apr. (NICE Guideline, No. 45.)
Care of Dying Adults in the Last Days of Life.
London: National Institute for Health and Care Excellence (NICE); 2015 Dec 16. (NICE Guideline, No. 31.)
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on